Lung Cancer Trial, Recruiting NCT03769129 Sponsor: Second Affiliated Hospital of Guangzhou Medical University Condition: Lung Cancer
Back to Lung Cancer

Lung Cancer Trial, Recruiting

NCT03769129
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with advanced non-small cell lung cancer (stage IIIB or IV), confirmed by a laboratory test.
  • Your first round of standard cancer treatment has stopped working or your cancer has come back after treatment.
  • You have at least one tumor that can be measured on a scan.
  • You have not received any cancer treatment in the last four weeks.
  • You are 18 years of age or older (any gender).
  • You are reasonably active and able to care for yourself, with only mild limitations in daily activity (confirm with trial site).
  • Doctors expect you to live for at least six months.
  • Your blood counts, liver, and kidney are functioning well enough to meet specific levels set by the trial (confirm exact values with trial site).
  • If you are a woman who could become pregnant, you have a negative pregnancy test and agree to use effective contraception during the trial and for six months after treatment ends.
  • You are willing to join voluntarily, sign a consent form, and attend follow-up appointments.

Who may not be able to join:

  • You have been diagnosed with two or more different types of cancer.
  • You have an active viral or bacterial infection that has not been controlled with treatment.
  • You have tested positive for HIV or syphilis, or have hepatitis B or hepatitis C that is not under control.
  • You have an active autoimmune or rheumatic disease, have had an organ transplant, or have another condition that seriously affects your immune system.
  • You have serious heart or lung problems.
  • You have severe long-term disease affecting your kidneys, liver, or other major organs.
  • You have any other serious illness that doctors feel could affect your treatment, monitoring, or results — including uncontrolled neurological, psychiatric, or metabolic conditions (confirm with trial site).
  • You are currently taking part in, or have taken part in, another clinical drug trial within the last 30 days.
  • You need to take immune-suppressing medicines long-term, or you are currently being treated for an autoimmune disease.
  • You need to take steroid medicines (such as corticosteroids) on a long-term basis.
  • You are currently pregnant or breastfeeding.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: zhang zhenfeng, MD,PHD, Second Affiliated Hospital of Guangzhou Medical University

Phone: 02034153532

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Second Affiliated Hospital of Guangzhou Medical University
Registry
ClinicalTrials.gov
Start date
1 November 2018
Est. completion
1 November 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Overall survival

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov